Area of research
Pulmonary and Respiratory Medicine · Pathology and Forensic Medicine
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, and Heart Failure Treatment and Management.
Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
A critical analysis of 57 cases of Hughes-Stovin syndrome (HSS). A report by the HSS International Study Group (HSSISG)
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide—a report by the HSS International Study Group
Treatment of pulmonary hypertension in patients with Hereditary Hemorrhagic Telangiectasia – A case series and systematic review
Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension
United States Pulmonary Hypertension Scientific Registry
Prevalence and Mortality of Pulmonary Hypertension in ESRD: A Systematic Review and Meta-analysis
Predicting Survival in Patients With Pulmonary Arterial Hypertension
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications
Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension
REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat
Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis
Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis
Practical considerations for therapies targeting the prostacyclin pathway
Ranolazine for the treatment of pulmonary hypertension associated with heart failure with preserved ejection fraction: A pilot study
Five-Year Outcomes of Patients Enrolled in the REVEAL Registry
Clinical features of pulmonary arterial hypertension in patients receiving dasatinib
Validation of two predictive models for survival in pulmonary arterial hypertension
Unique Predictors of Mortality in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis in the REVEAL Registry
Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance
Hospitalization and Survival in Patients Using Epoprostenol for Injection in the PROSPECT Observational Study
Comorbid Conditions and Outcomes in Patients With Pulmonary Arterial Hypertension
Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: Initial clinical experience
Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: Insights from the REVEAL Registry